The use of tumor-specific T cells reintroduced to patients requires all of the following EXCEPT

Question

Quizplus · Accepted Answer

Tumor-specific T cells reintroduced to patients do not require the depletion of autoreactive clones. This step is more relevant to autoimmune disease management, where autoreactive T cells are targeted for depletion to reduce autoimmunity. In cancer immunotherapy, the focus is on isolating, activating, and expanding tumor-specific T cells, and preparing the patient's immune system to receive these cells effectively.

The Use of Tumor-Specific T Cells Reintroduced to Patients Requires